collaborators

5 papers

stat.ME2025

Integrating Prioritized and Non-Prioritized Structures in Win Statistics

Yunhan Mou, Scott Hummel, Yuan Huang

Composite endpoints are frequently used as primary or secondary analyses in cardiovascular clinical trials to increase clinical relevance and statistical efficiency. Alternatively,…

stat.ME2025

A Non-Bipartite Matching Framework for Difference-in-Differences with General Treatment Types

Siyu Heng, Yuan Huang, Hyunseung Kang

Difference-in-differences (DID) is one of the most widely used causal inference frameworks in observational studies. However, most existing DID methods are designed for binary trea…

stat.ME2025

Correlation Matters! Streamlining the Sample Size Procedure with Composite Time-to-event Endpoints

Yunhan Mou, Fan Li, Denise Esserman +1

Composite endpoints are widely used in cardiovascular clinical trials to improve statistical efficiency while preserving clinical relevance. The Win Ratio (WR) measure and more gen…

stat.ME2025

Generalizing the Finkelstein-Schoenfeld Test to Incorporate Multiple Alternating Thresholds

Yunhan Mou, Tassos Kyriakides, Scott Hummel +2

Composite endpoints consisting of both terminal and non-terminal events, such as death and hospitalization, are frequently used in cardiovascular clinical trials. The Finkelstein-S…

stat.ME2025

Testing Prioritized Composite Endpoint with Multiple Follow-up Time Examinations

Yunhan Mou, Haitao Pan, Yu Jiang +1

Composite endpoints are widely used in cardiovascular clinical trials. In recent years, hierarchical composite endpoints-particularly the win ratio approach and its predecessor, th…